Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Net Income (2020 - 2025)

Journey Medical (DERM) has disclosed Net Income for 6 consecutive years, with -$2.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Net Income rose 3.14% year-over-year to -$2.3 million, compared with a TTM value of -$8.5 million through Sep 2025, up 53.41%, and an annual FY2024 reading of -$14.7 million, down 280.77% over the prior year.
  • Net Income was -$2.3 million for Q3 2025 at Journey Medical, up from -$3.7 million in the prior quarter.
  • Across five years, Net Income topped out at $16.8 million in Q3 2023 and bottomed at -$21.8 million in Q4 2021.
  • Average Net Income over 5 years is -$5.4 million, with a median of -$4.1 million recorded in 2025.
  • The sharpest move saw Net Income crashed 36810.34% in 2021, then soared 266.56% in 2023.
  • Year by year, Net Income stood at -$21.8 million in 2021, then skyrocketed by 51.07% to -$10.6 million in 2022, then soared by 79.86% to -$2.1 million in 2023, then soared by 173.82% to $1.6 million in 2024, then plummeted by 246.33% to -$2.3 million in 2025.
  • Business Quant data shows Net Income for DERM at -$2.3 million in Q3 2025, -$3.7 million in Q2 2025, and -$4.1 million in Q1 2025.